发明名称 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rnain patients having chronic hepatitis infection
摘要 5'-Amino acid esters of ribavirin represented by formula I:wherein R is CH3CH(NH2)-CO-, CH3CH2(CH3)CHCH(NH2)-CO-orH2N(CH2)4CH(NH2)-CO-; preferably R isor a pharmaceutically acceptable salt thereof, e.g., trifluoroacetate, tosylate, mesylate, and chloride, pharmaceutical compositions containing them as well as methods of treating patients having susceptible viral infections, e.g., chronic hepatitis C infections by administering a therapeutically effective amount of a ribavirin derivative, alone or in combination with a therapeutically effective amount of interferon-alpha are disclosed.
申请公布号 AU1197600(A) 申请公布日期 2000.05.08
申请号 AU20000011976 申请日期 1999.10.14
申请人 SCHERING CORPORATION 发明人 ASHIT K. GANGULY;JINPING MCCORMICK;RAYMOND G. LOVEY;FRANK BENNETT;ANIL K. SAKSENA;VIYYOOR M. GIRIJAVALLABHAN
分类号 C07H19/056 主分类号 C07H19/056
代理机构 代理人
主权项
地址